1. Home
  2. POAI vs GELS Comparison

POAI vs GELS Comparison

Compare POAI & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • GELS
  • Stock Information
  • Founded
  • POAI 2002
  • GELS 2018
  • Country
  • POAI United States
  • GELS Australia
  • Employees
  • POAI N/A
  • GELS N/A
  • Industry
  • POAI Industrial Specialties
  • GELS
  • Sector
  • POAI Health Care
  • GELS
  • Exchange
  • POAI Nasdaq
  • GELS NYSE
  • Market Cap
  • POAI 8.9M
  • GELS 8.7M
  • IPO Year
  • POAI N/A
  • GELS 2024
  • Fundamental
  • Price
  • POAI $1.06
  • GELS $1.90
  • Analyst Decision
  • POAI Hold
  • GELS
  • Analyst Count
  • POAI 1
  • GELS 0
  • Target Price
  • POAI N/A
  • GELS N/A
  • AVG Volume (30 Days)
  • POAI 313.3K
  • GELS 4.7M
  • Earning Date
  • POAI 05-13-2025
  • GELS 02-15-2025
  • Dividend Yield
  • POAI N/A
  • GELS N/A
  • EPS Growth
  • POAI N/A
  • GELS N/A
  • EPS
  • POAI N/A
  • GELS N/A
  • Revenue
  • POAI $1,623,817.00
  • GELS $95,618.00
  • Revenue This Year
  • POAI $486.27
  • GELS N/A
  • Revenue Next Year
  • POAI $65.50
  • GELS N/A
  • P/E Ratio
  • POAI N/A
  • GELS N/A
  • Revenue Growth
  • POAI N/A
  • GELS N/A
  • 52 Week Low
  • POAI $0.55
  • GELS $0.77
  • 52 Week High
  • POAI $3.06
  • GELS $5.50
  • Technical
  • Relative Strength Index (RSI)
  • POAI 47.00
  • GELS N/A
  • Support Level
  • POAI $0.85
  • GELS N/A
  • Resistance Level
  • POAI $1.44
  • GELS N/A
  • Average True Range (ATR)
  • POAI 0.11
  • GELS 0.00
  • MACD
  • POAI 0.00
  • GELS 0.00
  • Stochastic Oscillator
  • POAI 42.86
  • GELS 0.00

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About GELS GELTEQ LIMITED

Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.

Share on Social Networks: